Please assess the completion status of the following clinical trial:

Trial Title: Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven grade II, III, or IV astrocytoma or oligodendroglioma~  * Evidence of primary or recurrent tumor by MRI~ * Resectable disease~    * At least 20,000,000 viable cells obtained from surgical specimen for use in the immunization part of this study~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* SWOG 0 or 1~Life expectancy:~* At least 6 months~Hematopoietic:~* Granulocyte count at least 1,500/mm\^3~* Platelet count at least lower limit of normal~* No active or recent uncontrolled bleeding~Hepatic:~* Bilirubin normal~* SGOT no greater than 2 times upper limit of normal (ULN) (5 times ULN if liver metastases are present)~Renal:~* Creatinine normal~Other:~* Able to be weaned off steroids~* Negative stool guaiac~* No impaired immunity~* No uncontrolled diabetes~* No active uncontrolled infections~* No other serious disease~* No other malignancies within the past 5 years except curatively treated basal or squamous cell skin cancer or carcinoma in situ of the cervix~* No psychological, familial, sociological, or geographical conditions that would preclude compliance~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* No concurrent chemotherapy except for progressive disease~Endocrine therapy:~* See Disease Characteristics~Radiotherapy:~* Radium implants allowed~Surgery:~* Not specified~Other~* At least 1 week since prior therapy and recovered

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).